<!DOCTYPE html>
<html lang="en">

<head>
  <title>Antiplatlets | The Peripheral Brain</title>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">

  <script src='https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.2/MathJax.js?config=TeX-MML-AM_CHTML'></script>

  <link rel="stylesheet" href="/peripheral_brain/css/main.css" />
  <link rel="stylesheet" href="/peripheral_brain/css/mobile.css" />
  <link rel="stylesheet" href="/peripheral_brain/css/buttons.css" />

  
    <link rel="stylesheet" href="/peripheral_brain/css/diseases.css">
  


  <link href="https://fonts.googleapis.com/css?family=Open+Sans" rel="stylesheet">
  <link href="https://fonts.googleapis.com/css?family=Roboto" rel="stylesheet">
  <link href="https://fonts.googleapis.com/css?family=Roboto+Slab" rel="stylesheet">
  <link href="https://fonts.googleapis.com/css?family=Roboto+Mono" rel="stylesheet">
  <link href="https://fonts.googleapis.com/css?family=Roboto+Condensed" rel="stylesheet">


  <link rel="apple-touch-icon" sizes="180x180" href="/peripheral_brain/favicons/apple-touch-icon.png">
  <link rel="icon" type="image/png" sizes="32x32" href="/peripheral_brain/favicons/favicon-32x32.png">
  <link rel="icon" type="image/png" sizes="16x16" href="/peripheral_brain/favicons/favicon-16x16.png">
  <link rel="manifest" href="/peripheral_brain/favicons/site.webmanifest">
  <link rel="mask-icon" href="/peripheral_brain/favicons/safari-pinned-tab.svg" color="#465c8b">
  <link rel="shortcut icon" href="/peripheral_brain/favicons/favicon.ico">
  <meta name="apple-mobile-web-app-title" content="Peripheral Brain">
  <meta name="application-name" content="Peripheral Brain">
  <meta name="msapplication-TileColor" content="#da532c">
  <meta name="msapplication-config" content="/peripheral_brain/favicons/browserconfig.xml">
  <meta name="theme-color" content="#cdcdcd">


  

</head>


<body class="body">
<header id="myHeader" class="myHeader">
  <nav>
    <!-- <a href="/peripheral_brain/home.html"><img src="/peripheral_brain/images/logo_1000x1000.png" alt="Logo"> -->
    <a href="/peripheral_brain/home.html">Home</a>
    <a href="/peripheral_brain/disease_list.html">Diseases and Drugs</a>
    <a href="/peripheral_brain/firstFive">TF5M</a>
    <a href="/peripheral_brain/lab_values">Lab Values</a>
    <a href="/peripheral_brain/formulas">Formulas</a>
    <a href="/peripheral_brain/calculators.html">Calculators</a>
    <a href="/peripheral_brain/search.html">Search</a>
    <a href="javascript:void(0);" class="icon" onclick="openMenu()">&#9776;</a>
  </nav>

  <script>
  function openMenu() {
      var x = document.getElementById("myHeader");
      if (x.className === "myHeader") {
          x.className += " responsive";
      } else {
          x.className = "myHeader";
      }
  }
  </script>
</header>


<h1 class="title">Antiplatlets</h1>

<div class="contents twoCol">
  <div class="toc col1">
    
      <ul>
  <li><a href="#physiology">Physiology</a></li>
  <li><a href="#drug-classes">Drug Classes</a>
    <ul>
      <li><a href="#cox-1-inhibitors">COX-1 Inhibitors</a>
        <ul>
          <li><a href="#moa">MOA</a></li>
          <li><a href="#ses">SEs</a></li>
        </ul>
      </li>
      <li><a href="#adp-receptor-inhibitors">ADP Receptor Inhibitors</a>
        <ul>
          <li><a href="#moa-1">MOA</a></li>
          <li><a href="#drugs">Drugs</a></li>
        </ul>
      </li>
      <li><a href="#gp-iibiiia-inhibitors">GP IIb/IIIa Inhibitors</a>
        <ul>
          <li><a href="#moa-2">MOA</a></li>
          <li><a href="#drugs-1">Drugs</a></li>
        </ul>
      </li>
      <li><a href="#protease-activated-receptor-inhibitors">Protease Activated Receptor Inhibitors</a>
        <ul>
          <li><a href="#moa-3">MOA</a></li>
          <li><a href="#drugs-2">Drugs</a></li>
        </ul>
      </li>
    </ul>
  </li>
</ul>

    
  </div>

  <div class="content col2">
    <h1 id="physiology">Physiology</h1>
<p>In the presence of vascular injury, exposed basement membrane and collagen GP Ia on Plts binds to collagen, and VWF links collagen to GP Ib. Remaining endothelial cells secrete PGI<sub>2</sub> in an attempt to inhibit thrombosis (as they typically do). Following these binding events, plts degranulate and release ADP, 5-HT, and TXA<sub>2</sub> which activates other plts, and the 5-HT and TXA<sub>2</sub> also induce vasoconstriction to decrease blood flow to the area in an attempt to decrease hemorrhage and close the injury. Circulating thrombin can also activate plts via PAR-1 receptors. Following large-scale plt activation, which includes inducing conformation changes in the GP IIb/IIIa receptor, plts bind to fibrinogen via the GP IIb/IIIa, cross-linking the plts, and then the plts contract to irreversibly fuse the plt plug. Fibrin (from the coagulation cascade) then stabilizes and anchors the plt plug.</p>
<h1 id="drug-classes">Drug Classes</h1>
<h2 id="cox-1-inhibitors">COX-1 Inhibitors</h2>
<h3 id="moa">MOA</h3>
<p>ASA is the prototypical COX-1 inhibitor, which acts by <strong>irreversibly</strong> inhibiting COX-1 in the plts, inhibiting the formation of TXA<sub>2</sub> , which then helps to decrease plt activation. COX-1 specific inhibition does not significantly impact PGI<sub>2</sub> (prostacyclin) production in the vascular endothelia, which is one of the predominant anti-aggregation signaling molecules in plasma.</p>
<h3 id="ses">SEs</h3>
<ul>
  <li>Upper GI bleeding</li>
  <li>ASA overdose (commonly w/ &gt; 150 mg/kg, and &gt; 500 mg/kg can be fatal)
    <ul>
      <li>N / V / D / Fever / Coma / SIG Acidosis and Resp. Alkalosis</li>
    </ul>
  </li>
</ul>

<h2 id="adp-receptor-inhibitors">ADP Receptor Inhibitors</h2>
<h3 id="moa-1">MOA</h3>
<p>Both P2Y1 (Gq coupled) and P2Y12 (Gi coupled) must be activated to activate plts. Activation leads to GP IIb/IIIa conformation change.</p>
<h3 id="drugs">Drugs</h3>
<ul>
  <li>All target P2Y12 directly except Cilostazol</li>
  <li>Clopidogrel (Plavix)
    <ul>
      <li>Prodrug</li>
      <li>Irreversible binding</li>
    </ul>
  </li>
  <li>Prasugrel (Effient)
    <ul>
      <li>Prodrug</li>
      <li>Irreversible binding</li>
    </ul>
  </li>
  <li>Ticlopidine (Ticlid)
    <ul>
      <li>Prodrug</li>
      <li>Irreversible binding</li>
      <li>May induce TTP</li>
    </ul>
  </li>
  <li>Cangrelor (Kengreal)
    <ul>
      <li>Reversible binding</li>
    </ul>
  </li>
  <li>Ticagrelor (Brilinta)
    <ul>
      <li>Reversible, allosteric antagonist</li>
    </ul>
  </li>
  <li>Cilostazole
    <ul>
      <li>Inhibition of PDEIII intracellularly, mimicking the effects of P2Y12 blockade (blocking the inactivation of cAMP causing increased intracellular cAMP)</li>
      <li>Often given in combination with dipyridamole, which inhibits adenosine reuptake and inhibits adenosine breakdown, both of which increase cAMP</li>
    </ul>
  </li>
</ul>

<h2 id="gp-iibiiia-inhibitors">GP IIb/IIIa Inhibitors</h2>
<h3 id="moa-2">MOA</h3>
<p>Binds GP IIb/IIIa receptor in place of fibrinogen, which therefore prevents plt cross-linking</p>
<h3 id="drugs-1">Drugs</h3>
<ul>
  <li>Abciximab (ReoPro)
    <ul>
      <li>Ig against human GP IIb/IIIa</li>
    </ul>
  </li>
  <li>Eptifibitide (Integrilin)
    <ul>
      <li>Reversible inhibitor</li>
    </ul>
  </li>
  <li>Tirofiban (Aggrastat)
    <ul>
      <li>Reversible inhibitor</li>
    </ul>
  </li>
</ul>

<h2 id="protease-activated-receptor-inhibitors">Protease Activated Receptor Inhibitors</h2>
<h3 id="moa-3">MOA</h3>
<p>Activated thrombin activates plts through the PAR receptor, and vorapaxar induces clevage of PAR-1</p>
<h3 id="drugs-2">Drugs</h3>
<ul>
  <li>Vorapaxar (Zontivity)</li>
</ul>


  </div>

</div>

<div class="credits">
  <p>Author: Corbin Cox <br>
  Created: 2018-8-10 <br>
  Last Updated: 2018-8-10</p>
</div>

<footer class="footer menus">
  <nav>
    <div class="footerLinks">
      <a href="/peripheral_brain/home.html">Home</a>
      <a href="/peripheral_brain/index.html">Disclaimer</a>
    </div>
  </nav>
</footer>


</body>
</html>
